Epidarex Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
10
- Investments
-
73
- Portfolio
-
22
- Exits
-
11
Epidarex Capital General Information
Company Description
Founded in 2012, Epidarex Capital is a venture capital firm based in Bethesda, Maryland. The firm prefers to invest in the United States and United Kingdom-based companies operating in the life science, biotechnology, pharmaceuticals, medical devices, and health technology sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.epidarex.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Corporate Office
- 7910 Woodmont Avenue
- Suite 1315
- Bethesda, MD 20814
- United States
Epidarex Capital Investments (73)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| RougeTx | 06-Oct-2026 | Later Stage VC | Drug Discovery | Generating Revenue | ||
| Hawkhill Therapeutics | 28-Sep-2026 | Biotechnology | Startup | |||
| Mironid | 05-Aug-2026 | Therapeutic Devices | Generating Revenue | |||
| RapidPulse | 16-Jul-2026 | Therapeutic Devices | Clinical Trials - General | |||
| Leucid Bio | 01-Feb-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Harness Therapeutics | 20-Jan-2025 | Biotechnology | Pre-Clinical Trials | |||
| Epsilogen | 09-Sep-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Theolytics | 31-Aug-2024 | Drug Discovery | Clinical Trials - Phase 1 | |||
| Ryme Medical | 19-Aug-2024 | Early Stage VC | Drug Discovery | Startup | ||
| Kodikaz Therapeutic Solutions | 21-May-2024 | Later Stage VC | Drug Discovery | Pre-Clinical Trials |
Epidarex Capital Exits (11)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Rezera | 12-Nov-2026 | IPO | |
| Clyde Biosciences | 01-Mar-2026 | ||
| EM Imaging | 26-Aug-2025 | ||
| Kynos Therapeutics | 29-Oct-2024 | ||
| Caldan Therapeutics | 17-Sep-2024 | ||
| Sirakoss | 09-Nov-2020 | ||
| Enterprise Therapeutics (TMEM16A Potentiator Portfolio) | 07-Oct-2020 | ||
| Enterprise Therapeutics | 06-Oct-2020 | ||
| Apellis Pharmaceuticals | 09-Nov-2017 | IPO | |
| Confluence Discovery Technologies | 03-Aug-2017 | Merger/Acquisition |
Epidarex Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Epidarex Capital Investments by Industry, Year, and Region
Epidarex Capital Co-Investors (70)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Scottish Enterprise | 3 |
|
|
||
| BioGeneration Ventures |
|
|
|||
| IP Group |
|
|
|||
| Novartis Venture Fund |
|
|
|||
| Santé Ventures |
|
|
Epidarex Capital FAQs
-
What is Epidarex Capital?
Founded in 2012, Epidarex Capital is a venture capital firm based in Bethesda, Maryland.
-
When was Epidarex Capital founded?
Epidarex Capital was founded in 2010.
-
Where is Epidarex Capital headquartered?
Epidarex Capital is headquartered in Bethesda, MD.
-
What is Epidarex Capital's total asset value?
Epidarex Capital has around in total assets under management.
-
How many investments has Epidarex Capital made?
Epidarex Capital has made 73 investments.
-
What has Epidarex Capital invested in?
Epidarex Capital has made numerous investments in companies like RougeTx, Hawkhill Therapeutics, and Mironid within the Drug Discovery, Biotechnology, and Therapeutic Devices industries.
-
What has Epidarex Capital invested in recently?
Epidarex Capital's latest investment was on 06-Oct-2026 in RougeTx, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process